Cellebrite shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 revenue guidance above estimates. Also, the company issued Q3 revenue guidance above estimates.
Portfolio Pulse from Benzinga Newsdesk
Cellebrite shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 revenue guidance above estimates. Additionally, the company issued Q3 revenue guidance above estimates.
August 15, 2024 | 12:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cellebrite shares are trading higher following the release of better-than-expected Q2 financial results and an increase in FY24 revenue guidance above estimates. The company also issued Q3 revenue guidance above estimates.
The better-than-expected Q2 financial results and raised FY24 revenue guidance indicate strong performance and positive future outlook, which are likely to drive the stock price higher in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100